M. Belvisi (London, United Kingdom), D. Cataldo (Liege, Belgium)
Minimal clinically important difference (MCID) for the St. George‘s respiratory questionnaire (SGRQ) in chronic obstructive pulmonary disease (COPD)
P. R. Reese, G. Stynes, K. R. Friel (Cary, NC, United States Of America; Ingelheim, Germany; Guildford, Surrey, United Kingdom)
|   |
Levels of NO in exhaled air at patients with chronic obstructive pulmonary diseases in high altitude
A. Myrzaahmatova, T. Sooronbaev (Byshkek, Kyrgyzstan)
| |
An electronic health record improves outcomes in asthmatics outpatients
J. Bozzola, J. P. Arcos, B. Sosa, M. Contreras, L. M. Pineyro (Montevideo, Uruguay)
| |
Are there patient characteristics associated with improvements or worsening in the placebo arm of COPD tlinical trials?
A. Anzueto, D. Tashkin, S. Kesten (San Antonio, TX, Los Angeles, CA, United States Of America; Biberach, Germany)
| |
Training patients on how to use metered dose inhaler (MDI) by using the 2Tone will improve asthma quality of life (AQOL)
W. Tarsin, N. Hshad, I. Elshamli, M. Soussi, H. Chrystyn (Tripoli, Libyan Arab Jamahiriya; Huddersfield, United Kingdom)
| |
Renewed role of nitrogen slope of phase III in chronic obstructive pulmonary disease (COPD)
G. Catapano, F. Mannucci, G. Mirarchi, C. Carli, R. Prediletto (Pisa, Italy)
| |
A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
A. Nair, K. Clearie, D. Menzies, K. Meldrum, L. McFarlane, B. Lipworth (Dundee, United Kingdom)
| |
Use of multifactor-dimensionality reduction model predicting bronchodilator response by inhaled short-acting beta 2 agonist
S. H. Kim, S. M. Lee, S. H. Lee, E. S. Shin, J. E. Lee, H. W. Park, S. S. Kim, S. H. Cho, K. U. Min, Y. Y. Kim (Seoul, Republic Of Korea)
| |
Sputum assessment in asthma management does not improve disease control when GINA step-up treatment is used in mild-to-moderate patients
E. Bacci, M. Bartoli, S. Cianchetti, L. Melosini, L. Malagrinò, F. Novelli, F. Costa, M. De Santis, P. Paggiaro (Pisa, Italy)
| |
Change of inhalation device: impact on asthma control and compliance in general practice. SYSTER survey
V. Giraud, F. A. Allaert (Boulogne, Dijon, France)
| |
Efficacy of tiotropium bromide in patients with chronic obstructive pulmonary disease of varying severity
H. K. Yum, I. N. Park, S. B. Choi, H. Jung, J. W. Hur, H. K. Lee, S. S. Lee, H. P. Lee, S. J. Choi (Seoul, Republic Of Korea)
| |
Efficacy of budesonide/formoterol in Chinese patients with chronic obstructive pulmonary disease
N. Zhong, T. P. Larsson, S. Peterson, U. Nihlén (Guangzhou, China; Lund, Sweden)
| |
Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma
M. Adachi (Tokyo, Japan)
| |
Innovative home management plan for better asthma management
P. Swamy (Jabalpur{MP}, India)
| |
Development of the morning activities and symptoms questionnaire (MASQ) for COPD
M. R. Partridge, N. Karlsson, E. Stahl (London, United Kingdom; Mölndal, Lund, Sweden)
| |
Assessing overall asthma control with budesonide/formoterol maintenance + relief in moderate/severe asthma
E. D. Bateman, P. M. O‘Byrne (Cape Town, South Africa; Hamilton, ON, Canada)
| |
Preventing asthma exacerbations with budesonide/formoterol maintenance + relief: a pooled analysis
P. M. O‘Byrne, E. D. Bateman (Hamilton, ON, Canada; Cape Town, South Africa)
| |
Overall asthma control with budesonide/formoterol maintenance and relief vs conventional best practice
P. Demoly, R. Louis, U. Søes-Petersen, H. Worth, J. Almeida, M. R. Sears (Montpellier, France; Liege, Belgium; Roskilde, Denmark; Fürth, Germany; Porto, Portugal; Hamilton, ON, Canada)
| |
Fluticasone and montelukast in school children with asthma
Z. Paunovic (Nis, Serbia And Montenegro)
| |
A comparison of CT densitometric indices for the assessment of AAT augmentation therapy
D. G. Parr, A. Dirksen, E. Piitulainen, C. Deng, M. Wencker, R. A. Stockley (Coventry, Birmingham, United Kingdom; Hellerup, Denmark; Malmo, Sweden; North Carolina, United States Of America; Frankfurt, Germany)
| |